A clinical study of Hwangryunhaedoktang in adult atopic dermatitis : a randomised, double-blind, placebo-controlled, multicentre trial

Korea Health Industry Development Institute (KHIDI)0 个研究点目标入组 100 人开始时间: 2010年7月29日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Age greater than 19 years, either sex
•2. Typical conditions of intermittent or continuous atopic eczema
•2.1. Duration of more than 6 months
•2.2. Satisfied Hanifin and Rajka?s criteria for atopic dermatitis
•3. Diagnosed with adult atopic dermatitis by two different oriental medicine doctors
•4. Written and informed consent

•1. Other dermatitis or systemic disease except for atopic eczema
•2. Administration of steroids and immunosuppressant per os (by mouth) within one week from the interview (topical application not relevant)
•3. Women who are pregnant, lactating or without contraception
•4. Clinical severe hepatic disease or abnormal liver function tests at least twice the upper limit of normal
•5. Other clinical trial within the last 1 month
•6. Hypersensitivity or allergy of drugs
•7. Disease which can affect the absorption of drugs or disordered digestion after surgery related to the disease
•8. Cannot understand written consent or follow this study:
•8.1. Mental retardation
•8.2. Mental or emotional problems
•9. Judged by expert as inappropriate to participate in this study

发起方

Korea Health Industry Development Institute (KHIDI)